stella
beta
Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell) — Stella
Recruiting
Back to Respiratory Syncytial Virus (RSV) trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(8 sites)
China
Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangdong
Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei
Henan Center for Disease Control and Prevention, Zhengzhou, Henan
Hubei Provincial Center for Disease Control and Prevention, Wuhan, Hubei
Hunan Provincial Center for Disease Control and Prevention, Changsha, Hunan
Show all 8 locations
View full record on ClinicalTrials.gov